Literature DB >> 11349205

Fetal protein loss in gastroschisis as an explanation of associated morbidity.

S G Carroll1, P Y Kuo, P M Kyle, P W Soothill.   

Abstract

OBJECTIVE: Our purpose was to examine whether protein deficiency in utero develops in fetuses with gastroschisis. STUDY
DESIGN: Twelve infants with prenatally diagnosed gastroschisis were compared with 29 control infants without gastroschisis and 2 infants with exomphalos who were delivered between 35 and 42 weeks of gestation. The groups were compared for birth weight, cord serum total protein and amniotic fluid total protein, and alpha-fetoprotein concentrations. The amniotic fluid samples were collected when the amniotic membranes were ruptured either during cesarean delivery or at artificial rupture of the membranes, and umbilical cord blood was obtained after delivery.
RESULTS: In the 10 cases of gastroschisis in which cord serum total protein was measured, the median concentration was 51 g/L (range, 43-61 g/L) and was significantly lower than the median level of 62 g/L (range, 47-78 g/L) in the control group (P <.001). In the 8 cases of gastroschisis in which amniotic fluid total protein and alpha-fetoprotein concentrations were measured, the respective median levels were 5.1 g/L (range, 4.3-18.4 g/L) and 5.0 g/L (range, 2.4-13.2 g/L), which were significantly higher than the median levels of 2.0 g/L (range, 0.5-5.4 g/L) and 0.8 g/L (range, 0.5-1.7 g/L) in the control group (P <.0001). The ratio of amniotic fluid to cord serum total protein was significantly higher than that in the cases of exomphalos and in the control group (P <.001). The median birth weight in the neonates with gastroschisis was 2400 g (range, 1192-3155 g) and was significantly lower than the median value of 3535 g (range, 2520-4680 g) in the control group (P <.0001).
CONCLUSIONS: Fetuses with gastroschisis have protein loss that could partly explain associated morbidity. However, whether this is a major contributor to poor fetal outcome remains to be shown.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349205     DOI: 10.1067/mob.2001.114031

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Evolution of critically ill patients with gastroschisis from three tertiary centers.

Authors:  Ana Cristina A Tannuri; Lourenço Sbragia; Uenis Tannuri; Luanna M Silva; Antonio José G Leal; Augusto Frederico S Schmidt; Antonio G Oliveira-Filho; Joaquim Murray Bustorff-Silva; Yvone A M V A Vicente; Maria de Fátima G S Tazima; Flávio O Pileggi; Alexandra L Camperoni
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

2.  Does administering albumin to postoperative gastroschisis patients improve outcome?

Authors:  Ana Cristina A Tannuri; Luanna M Silva; Antonio José G Leal; Augusto César F de Moraes; Uenis Tannuri
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

3.  Growth restriction in gastroschisis: quantification of its severity and exploration of a placental cause.

Authors:  Nathaniel R Payne; Susan C Simonton; Sam Olsen; Mark A Arnesen; Kathleen M Pfleghaar
Journal:  BMC Pediatr       Date:  2011-10-17       Impact factor: 2.125

4.  Interval growth across gestation in pregnancies with fetal gastroschisis.

Authors:  Kathy Zhang-Rutledge; Marni Jacobs; Elizabeth Patberg; Nancy Field; Kerry Holliman; Katie M Strobel; Aisling Murphy; Diana Robles; Naseem Rangwala; Juan M Gonzalez; Teresa N Sparks
Journal:  Am J Obstet Gynecol MFM       Date:  2021-05-31

5.  Ultrasound markers for prediction of complex gastroschisis and adverse outcome: longitudinal prospective nationwide cohort study.

Authors:  C C M M Lap; L R Pistorius; E J H Mulder; M Aliasi; W L M Kramer; C M Bilardo; T E Cohen-Overbeek; E Pajkrt; D Tibboel; R M H Wijnen; G H A Visser; G T R Manten
Journal:  Ultrasound Obstet Gynecol       Date:  2020-06       Impact factor: 7.299

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.